Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

TCR (T Cell Receptor) for identifying S183-91 epitope of hepatitis B virus (HBV) surface antigen and application of TCR

A technology of surface antigens and epitopes, applied in the direction of receptors/cell surface antigens/cell surface determinants, viruses, viral peptides, etc., can solve the problems of unrealistic bone marrow transplantation and failure to make people see hope, and achieve strong The effect of lethality

Active Publication Date: 2018-03-23
许嘉峰
View PDF1 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is obviously unrealistic to perform bone marrow transplantation only because of chronic HBV infection
In addition, the attempt of vaccination to eliminate HBV by enhancing the immunity of chronic hepatitis B patients has not yet given hope

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • TCR (T Cell Receptor) for identifying S183-91 epitope of hepatitis B virus (HBV) surface antigen and application of TCR
  • TCR (T Cell Receptor) for identifying S183-91 epitope of hepatitis B virus (HBV) surface antigen and application of TCR
  • TCR (T Cell Receptor) for identifying S183-91 epitope of hepatitis B virus (HBV) surface antigen and application of TCR

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0104] Example 1 Cloning the TCR gene of HBVS183-91 epitope-specific T cells

[0105] Peripheral blood lymphocytes (PBL) were isolated from fresh blood obtained from recovered HBV-infected volunteers with HLA type HLA-A*0201.

[0106] Firstly, PBL was isolated by Ficoll-Hypaque (GE) density gradient centrifugation. Then the PBL was washed with DPBS (Life), resuspended in RPMI medium (Life) (2% human Serum), and a final concentration of 1uM of HBV S183-91 polypeptide (FLLTRILTI, SEQ ID NO: 31; Gensiray) was added. ) and 20 IU / ml interleukin 2 (IL-2; peprotech), cultured in 24-well plate for 10 days.

[0107] After 10 days, according to the instructions of the IFN-γSecretion Assay cell enrichment and detection kit (Miltenyi), after further stimulation with 10uM S183-91 polypeptide, CD8+ and IFN-γ double-positive cells were sorted by flow cytometry (Moflo XDP, Beckman Coulter). Single cells (for sorting results, see figure 1 ) into a 96-well PCR plate, centrifuged and placed a...

Embodiment 2

[0109] Example 2 Preparation of lentivirus containing TCR chain

[0110] After the above-mentioned TCR gene initially verified by IMGT was synthesized into a gene fragment (BGI&Genecreate), it was assembled into a complete TCR chain by the method of overlap PCR, wherein the constant region of TCR was replaced by the constant region of mouse origin (CJ , Y et al.2006), in order to avoid the mismatch between the imported TCR and the endogenous TCR gene and to facilitate subsequent testing of TCR gene expression. The PCR product was cut with NotI and NheI (FastDigest, Life) and then subcloned into the pHAGE vector.

[0111] After the correct sequence was verified by sequencing, 293T cells were co-transfected with psPAX2 and pMD2.G 3 plasmid packaging system. 24 hours after transfection, collect the first batch of lentiviral supernatant; 48 hours later, collect the second batch of lentiviral supernatant.

Embodiment 3

[0112] Example 3 Transfection of T cells and pentamer binding ability of T cells after transfection.

[0113] After stimulating the PBL obtained by Ficoll-Hypaque with OKT-3 (Biolegend) and IL-2 for 24 hours, add lentiviral supernatant and polybrene (sigma, final concentration 8ug / mL) at 1:1, centrifuge at 1000g for 60 minutes, put Return to 37°C incubator. After 4 hours, replace with fresh cRPMI medium. The components of cRPMI medium are 10% heat-inactivated FBS, 1X GlutaMax, 1Xsodium pyruvate, 1XHEPES (all from Gibco, Life), 50uM 2-ME (sigma), penicilin / streptomycin (Hangzhou Keyi).

[0114] After 24 hours, aspirate half of the medium, re-add an equal volume of lentiviral supernatant, supplement polybrene to a final concentration of 8ug / ml, and centrifuge at 1000g for 60 minutes. Change back to cRPMI medium after 4 hours. (same as the first transfection).

[0115] After 2-7 days of transfection, collect the cells, wash the cells with Wash buffer (0.5% BSA in PBS) accordi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for separating an antigen-specificity T cell and cloning and encoding an antigen-specificity TCR gene from the antigen-specificity T cell. The invention also providesa nucleic acid molecule of the TCR for encoding the specificity of an HBV surface antigen S183-91, and a carrier containing the nucleic acid molecule. The TCR disclosed by the invention can be combined with an HBV S183-91 antigen short peptide complex FLLTRILTI-HLA*A0201; meanwhile, a cell of the TCR disclosed by the invention is transduced, can be specifically activated, and has a strong killingeffect on target cells.

Description

technical field [0001] The present invention relates to a TCR capable of recognizing short peptides derived from the HBV S183-91 antigen. The present invention also relates to the S183-91-specific T cells obtained by transducing the above TCR, and their use in the prevention and treatment of HBV infection-related diseases . Background technique [0002] Hepatitis B virus (HBV) infects the liver of the human superfamily (including humans) and causes an inflammation called hepatitis. It is a DNA virus and is one of several separate viruses that cause viral hepatitis. Chronic HBV infection can eventually lead to cirrhosis and hepatocellular carcinoma (HCC), a fatal disease that responds very poorly to current chemotherapy. [0003] Existing drugs for the treatment of HBV infection can only inhibit rather than eliminate HBV. Although the majority of HBV-infected patients respond to currently available therapies, showing improvement in liver histology and serum alanine aminotr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/02C07K14/725C12N15/12C12N5/10A61K38/17A61K35/17A61P31/20A61P35/00
CPCC12N5/0636C07K14/005C07K14/7051A61K38/00C12N2760/16222C12N2510/00A61K39/4632A61K39/464838A61K39/4611
Inventor 许嘉峰夏总平
Owner 许嘉峰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com